CompletedPhase 2NCT00971620
Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin
Studying Hereditary leiomyomatosis and renal cell cancer
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Edward W Cowen, M.D.National Cancer Institute (NCI)
- Intervention
- Botulinum toxin type A(biological)
- Enrollment
- 18 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2016
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00971620 on ClinicalTrials.gov